NGNE Financials | Income, Balance Sheet & Cash Flow
The financial statements for NGNE (NGNE) provide a snapshot of revenue trends, balance-sheet strength, and cash flow quality. Reviewing these together helps investors evaluate earnings durability, capital structure, and whether operating cash flow supports long-term business growth.
See stock fair value and complete historical financials—premium unlocks deeper tables and metrics.
Financial Statements
Related peers
Compare More →| QSI Quantum-Si incorporated | $1.04 -0.95% |
| SLDB Solid Biosciences Inc. | $8.39 +0.84% |
| BNTC Benitec Biopharma Inc. | $13.46 -1.03% |
| E Eni S.p.A. | $55.39 +2.16% |
| AUTL Autolus Therapeutics plc | $1.61 +8.05% |
| FULC Fulcrum Therapeutics, Inc. | $7.99 -3.15% |
| Peer | Price | Change | Market Cap | PE | EPS | Div Yield (TTM) | Analyst Rating | Volume |
|---|---|---|---|---|---|---|---|---|
| QSI Quantum-Si incorporated | $1.04 | -0.95% | 204.29 M | -2.04 | -0.51 | 0.00% | Buy | 7.34 |
| SLDB Solid Biosciences Inc. | $8.39 | +0.84% | 653.67 M | -4.22 | -1.99 | 0.00% | Buy | 672 |
| BNTC Benitec Biopharma Inc. | $13.46 | -1.03% | 353.29 M | -12.46 | -1.08 | 0.00% | Buy | 122 |
| E Eni S.p.A. | $55.39 | +2.16% | 81.67 B | 30.27 | 1.83 | 4.40% | Hold | 616 |
| AUTL Autolus Therapeutics plc | $1.61 | +8.05% | 428.49 M | -1.49 | -1.08 | 0.00% | Buy | 1.59 |
| FULC Fulcrum Therapeutics, Inc. | $7.99 | -3.15% | 432.35 M | -6.77 | -1.18 | 0.00% | Buy | 989 |
Frequently Asked Questions
What are NGNE's latest financial results?
Review NGNE's latest balance sheet, income statement, and cash flow to understand its profitability, revenue trends, and financial health. These metrics are essential for evaluating short-term performance and long-term stability.
How has NGNE's revenue and net income changed over time?
Analyzing historical revenue and net income shows growth trends and business performance. Consistent growth indicates operational strength, while declines may signal challenges that investors should consider.
What is NGNE's cash flow situation and liquidity?
Cash flow statements reveal how NGNE generates and uses cash. Strong operating cash flow and sufficient liquidity suggest the company can fund operations, pay dividends, and handle debt effectively.
How does NGNE's financial performance compare to industry peers?
Comparing key metrics like revenue growth, profit margins, and debt levels with competitors helps investors assess whether NGNE is outperforming or lagging within its sector.
Are NGNE's financial statements showing sustainable profitability?
By analyzing margins, ROE, ROIC, and cash generation over multiple periods, investors can evaluate whether NGNE's profits are repeatable and supported by strong fundamentals.